Why Choose EVO ICL to Improve Vision?
Have you heard about EVO ICL? Are you seeking an EVO ICL Dallas specialist? Many vision correction procedures promise an improved level of vision, but few vision correction options offer the quality and features found with the EVO ICL. Namely:
- Does not induce dry eye syndrome ;
- Sharp, Clear Vision , , ;
- Excellent Night Vision ;
- Great for those with thin corneas , ;
- UV protection built into the biocompatible lenses;
- A typically quick, 20-30 minute or less procedure and most people are able to resume daily activities in just a few short days with clearer vision
- Treats moderate to high myopia (nearsightedness).
Removability for Your Peace of Mind
The advantage of the EVO ICL is that it can permanently correct your vision, yet no natural tissue is removed in any way during the procedure. If for the unlikely reason you need or wish to remove your EVO ICLs in the future, your doctor can accommodate you.
Vision Correction with a Legacy of Success
EVO ICL has been approved in Europe since 1997 and in the U.S. since 2005. In that time, over 550,000 eyes have been implanted with EVO ICLs by certified, specialized surgeons with a study showing a 99% patient satisfaction rate.
In Harmony with Your Natural Eye
For people who value health and wellness, the EVO ICL could be the choice for you. The Collamer base of the lens material is biocompatible, meaning it is designed to function in harmony with your natural eye.
Can EVO ICL Correct My Vision?
EVO ICL is intended to correct moderate to high nearsightedness (-3.0 to -20.0). In general, Dr. George will require that your vision is stable for at least a year before he will agree to perform this procedure.
Are You a Candidate?
Among the best EVO ICL has to offer can be a terrific way to improve your vision, but the procedure is not right for everyone. In general, you will need to meet the following requirements to be considered an ideal candidate for implantable contact lenses:
- Between the ages of 21 and 45.
- Possess acceptable anterior chamber depth and eye tissue cell density (this will be determined by Dr. George during a comprehensive eye exam).
- No known allergies to medications used during refractive surgery.
- No history of eye surgery or disease, such as iritis or glaucoma.
- Stable vision for more than one year.
- Not currently pregnant or nursing.
What to Expect During the Procedure
To begin surgery, EVO ICL™️️️ Certified Surgeon, Dr. George will apply a topical anesthetic and sedative to minimize discomfort and ensure that you’re at ease throughout the procedure. From there, he will create one or two very small incisions at the base of the cornea and apply a gel-like substance to protect your eye, before delicately placing your implantable contact lens. The entire procedure takes about 30 minutes to complete and you should notice an immediate improvement in your vision. Additionally, you should be able to resume your normal daily routine within a day or two.
Once the procedure is complete, we will provide you with eye drops to use for several days. These drops will reduce the risk of infection and inflammation. You’ll need to have a friend or family member take you home, as you won’t be able to drive. Dr. George will want to see you within 24 hours to monitor your eye’s internal pressure and ensure that you’re progressing as planned.
How can I Finance the EVO ICL?
We accept payment by Visa, MasterCard, Bank Check or Cash. We also offer interest free payment plans to make your procedure more affordable. Financing options available through Care Credit or Alpheon Credit allow you to pay off your procedure for up to 18 months at 0% interest and extended financing for up to 60 months.
Dallas EVO ICL Surgeons
Not every eye surgeon in Dallas can be certified for this lens implant. Because Dr. George is one of Dallas’s leading edge ophthalmologists he has been selected and furthermore certified to implant the EVO ICL. Please contact our office directly if you feel this is a good option for you and Dr. George will provide a consultation with the EVO ICL ophthalmology team for you!
 By not removing and reshaping corneal tissue, the EVO ICL procedure does not induce dry eye syndrome.
Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
 Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.
 Shin, JY. Ahn, H. Seo, KY. Kim, EK. Kim, TK. Comparison of higher order aberrations after implantable collamer lens implantation and wavefront-guided lasek in high myopia. J Refract Surg. 2012; 28(2): 106-111.
 Igarashi, A. Kamiya, K. Shimizu, K. Komatsu, M. Visual Performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009.
 Parkhurst, G. Prospective Comparative Trial of LASIK vs. ICL for Night Vision Performance. Presented at the Annual Meeting of the AAO, Chicago, 2010.
 Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the EVO ICL. J Refract Surg. 2011;27(7):473-481.
 Gimbel, Howard V et al. Management of myopic astigmatism with phakic intraocular lens implantation. Journal of Cataract & Refractive Surgery , Volume 28 , Issue 5 , 883 – 886.
 EVO ICL Patient Information Booklet